HK1231493A1 - 药学上相关的芳香族阳离子肽 - Google Patents
药学上相关的芳香族阳离子肽 Download PDFInfo
- Publication number
- HK1231493A1 HK1231493A1 HK17105171.1A HK17105171A HK1231493A1 HK 1231493 A1 HK1231493 A1 HK 1231493A1 HK 17105171 A HK17105171 A HK 17105171A HK 1231493 A1 HK1231493 A1 HK 1231493A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cationic peptides
- pharmaceutically relevant
- peptides
- relevant aromatic
- phe
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461947286P | 2014-03-03 | 2014-03-03 | |
| US201461947286P | 2014-03-03 | ||
| PCT/US2014/072267 WO2015134096A1 (en) | 2014-03-03 | 2014-12-23 | Pharmaceutically relevant aromatic-cationic peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1231493A1 true HK1231493A1 (zh) | 2017-12-22 |
Family
ID=54055710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK17105171.1A HK1231493A1 (zh) | 2014-03-03 | 2014-12-23 | 药学上相关的芳香族阳离子肽 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20170081363A1 (enExample) |
| EP (1) | EP3114136A4 (enExample) |
| JP (1) | JP2017512762A (enExample) |
| CN (1) | CN106459169A (enExample) |
| CA (1) | CA2942143A1 (enExample) |
| HK (1) | HK1231493A1 (enExample) |
| WO (1) | WO2015134096A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015100376A1 (en) | 2013-12-27 | 2015-07-02 | Stealth Peptides International, Inc. | Pharmaceutically relevant aromatic-cationic peptides |
| EP3800192A1 (en) | 2015-03-06 | 2021-04-07 | Stealth Biotherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
| JPWO2017043626A1 (ja) * | 2015-09-11 | 2018-06-21 | 株式会社カネカ | 光学活性４−カルバモイル−２，６−ジメチルフェニルアラニン誘導体の製造法 |
| AU2017249218B2 (en) | 2016-04-11 | 2020-08-27 | Arcuate Therapeutics, Inc. | Chiral peptides |
| WO2018187400A1 (en) | 2017-04-05 | 2018-10-11 | Stealth Biotherapeutics Corp. | Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2 |
| US20200361987A1 (en) * | 2017-11-15 | 2020-11-19 | Stealth Biotherapeutics Corp. | Deuterated tetrapeptides that target mitochondria |
| US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
| EP3898653A4 (en) | 2018-12-18 | 2022-08-24 | Stealth BioTherapeutics Inc. | ANALOGS TARGETING MITOCHONDRIAL DISEASES |
| JPWO2023132352A1 (enExample) * | 2022-01-06 | 2023-07-13 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002000263A2 (en) * | 2000-06-14 | 2002-01-03 | Medarex, Inc. | Tripeptide prodrug compounds |
| US7704954B2 (en) * | 2003-05-01 | 2010-04-27 | Cornell Research Foundation, Inc. | Method and carrier complexes for delivering molecules to cells |
| US20070213505A1 (en) * | 2006-03-08 | 2007-09-13 | David Epstein | Solution Synthesis of Peptide Cell Growth Stimulators |
| WO2011116007A1 (en) * | 2010-03-15 | 2011-09-22 | Stealth Peptides International, Inc. | Combination therapies using cyclosporine and aromatic cationic peptides |
| CN105126071A (zh) * | 2011-06-14 | 2015-12-09 | 康肽德生物医药技术有限公司 | 芳香族阳离子肽及其用途 |
| HK1204988A1 (en) * | 2012-02-22 | 2015-12-11 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating ophthalmic conditions |
| EP3459598A1 (en) * | 2012-12-06 | 2019-03-27 | Stealth Peptides International, Inc. | Combinations of peptide therapeutics and methods for using same |
-
2014
- 2014-12-23 WO PCT/US2014/072267 patent/WO2015134096A1/en not_active Ceased
- 2014-12-23 EP EP14884543.1A patent/EP3114136A4/en not_active Withdrawn
- 2014-12-23 CA CA2942143A patent/CA2942143A1/en not_active Abandoned
- 2014-12-23 CN CN201480078597.XA patent/CN106459169A/zh active Pending
- 2014-12-23 HK HK17105171.1A patent/HK1231493A1/zh unknown
- 2014-12-23 US US15/123,437 patent/US20170081363A1/en not_active Abandoned
- 2014-12-23 JP JP2016555478A patent/JP2017512762A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN106459169A (zh) | 2017-02-22 |
| WO2015134096A1 (en) | 2015-09-11 |
| EP3114136A4 (en) | 2017-11-01 |
| JP2017512762A (ja) | 2017-05-25 |
| US20170081363A1 (en) | 2017-03-23 |
| EP3114136A1 (en) | 2017-01-11 |
| CA2942143A1 (en) | 2015-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1231493A1 (zh) | 药学上相关的芳香族阳离子肽 | |
| PL3531852T3 (pl) | System wytwarzania aerozolu, zastosowanie materiału zużywalnego w systemie i sposób wytwarzania aerozolu | |
| MX2020004073A (es) | Procesos de siembra en serie y usos de los mismos. | |
| SG10201803042PA (en) | Anti-tim-3 antibodies | |
| WO2015179691A3 (en) | Cell penetrating peptides and methods of making and using thereof | |
| EP3200812A4 (en) | Novel 4 7 peptide monomer and dimer antagonists | |
| SG10201808259TA (en) | Anti-jagged1 antibodies and methods of use | |
| AU2015286721B2 (en) | Influenza virus vaccines and uses thereof | |
| WO2016125192A3 (en) | Processes for the preparation of dolute-gravir | |
| AU2015352158A8 (en) | Medicaments for slowing Parkinson's Disease | |
| EP3236992A4 (en) | Peptides and their use in the treatment of skin | |
| PH12016501689A1 (en) | Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof | |
| HK1223298A1 (zh) | 预防和治疗组织损伤相关疾病和病症的组织保护肽和肽类似物 | |
| MX2016013589A (es) | Composiciones que comprenden derivados de osteopontina para la inhibicion del crecimiento de pelo. | |
| EP3237374A4 (en) | Amino acid and peptide conjugates and uses thereof | |
| EP3263584A4 (en) | Peptide for targeting autophagic cells and use thereof | |
| EP3341739A4 (en) | MUTATED PEPTIDES AND METHOD FOR TREATING SUBJECTS THEREWITH | |
| EP3230301A4 (en) | Gpc3 epitope peptides for th1 cells and vaccines containing the same | |
| AU359863S (en) | Endoscope system workstation | |
| EP3240540A4 (en) | Hdac1,2 inhibitors and methods of using the same | |
| EP3166406A4 (en) | Cytokine-chitosan bioconjugates and methods of using the same | |
| KR101646325B9 (ko) | 해양 미세조류 스피루리나 속 소화가수분해물 및 이로부터 유래된 펩타이드를 유효성분으로 함유하는 고혈압 예방 및 치료용 조성물 | |
| PL3526244T3 (pl) | Peptydy pochodzące z propeptydu ntsr3 i ich zastosowanie w leczeniu depresji | |
| EP3475293A4 (en) | NEW CYCLIC PEPTIDES AND USES THEREOF | |
| EP3288963A4 (en) | Pink1 c-terminal domain polypeptide and methods using the same in cancer treatment |